243 related articles for article (PubMed ID: 14651981)
21. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
[TBL] [Abstract][Full Text] [Related]
22. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
Hofmann TJ; Cole MD
Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
[TBL] [Abstract][Full Text] [Related]
23. Sequence determinants of DNA binding by the hematopoietic helix-loop-helix transcription factor TAL1: importance of sequences flanking the E-box core.
Gould KA; Bresnick EH
Gene Expr; 1998; 7(2):87-101. PubMed ID: 9699481
[TBL] [Abstract][Full Text] [Related]
24. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
25. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
[TBL] [Abstract][Full Text] [Related]
27. T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.
Rogers H; Wang L; Yu X; Alnaeeli M; Cui K; Zhao K; Bieker JJ; Prchal J; Huang S; Weksler B; Noguchi CT
J Biol Chem; 2012 Oct; 287(44):36720-31. PubMed ID: 22982397
[TBL] [Abstract][Full Text] [Related]
28. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
Curry JD; Smith MT
Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
[TBL] [Abstract][Full Text] [Related]
29. SCL/TAL1: a multifaceted regulator from blood development to disease.
Porcher C; Chagraoui H; Kristiansen MS
Blood; 2017 Apr; 129(15):2051-2060. PubMed ID: 28179281
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
[TBL] [Abstract][Full Text] [Related]
31. Gradient of E2A activity in B-cell development.
Herblot S; Aplan PD; Hoang T
Mol Cell Biol; 2002 Feb; 22(3):886-900. PubMed ID: 11784864
[TBL] [Abstract][Full Text] [Related]
32. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
Huang S; Qiu Y; Stein RW; Brandt SJ
Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
[TBL] [Abstract][Full Text] [Related]
33. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis.
Drake CJ; Brandt SJ; Trusk TC; Little CD
Dev Biol; 1997 Dec; 192(1):17-30. PubMed ID: 9405094
[TBL] [Abstract][Full Text] [Related]
34. Target-dependent effect of phosphorylation on the DNA binding activity of the TAL1/SCL oncoprotein.
Prasad KS; Brandt SJ
J Biol Chem; 1997 Apr; 272(17):11457-62. PubMed ID: 9111058
[TBL] [Abstract][Full Text] [Related]
35. ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.
Leong WZ; Tan SH; Ngoc PCT; Amanda S; Yam AWY; Liau WS; Gong Z; Lawton LN; Tenen DG; Sanda T
Genes Dev; 2017 Dec; 31(23-24):2343-2360. PubMed ID: 29326336
[TBL] [Abstract][Full Text] [Related]
36. The Tal1 oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition.
Park ST; Sun XH
J Biol Chem; 1998 Mar; 273(12):7030-7. PubMed ID: 9507011
[TBL] [Abstract][Full Text] [Related]
37. [Tal1 promotes proliferation of acute lymphoblastic leukemia Jurkat cells in vitro].
Wang Y; Shu Y; Yuan J; Chen H; Zou L
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):78-82. PubMed ID: 26806743
[TBL] [Abstract][Full Text] [Related]
38. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
39. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3.
Ono Y; Fukuhara N; Yoshie O
Mol Cell Biol; 1998 Dec; 18(12):6939-50. PubMed ID: 9819382
[TBL] [Abstract][Full Text] [Related]
40. GATA-binding protein 4 (GATA-4) and T-cell acute leukemia 1 (TAL1) regulate myogenic differentiation and erythropoietin response via cross-talk with Sirtuin1 (Sirt1).
Wang L; Jia Y; Rogers H; Wu YP; Huang S; Noguchi CT
J Biol Chem; 2012 Aug; 287(36):30157-69. PubMed ID: 22773876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
